Cite

HARVARD Citation

    Morita, M. et al. (n.d.). 486PPhase II study of low-dose afatinib maintenance treatment for patients with EGFR-mutated non-small cell lung cancer (NJLCG1601). Annals of oncology. p. . [Online]. 
  
Back to record